Mereo BioPharma Group Statistics
Total Valuation
MREO has a market cap or net worth of $40.32 million. The enterprise value is $11.23 million.
| Market Cap | 40.32M |
| Enterprise Value | 11.23M |
Important Dates
The last earnings date was Tuesday, August 11, 2026, before market open.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MREO has 159.69 million shares outstanding. The number of shares has increased by 2.30% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 159.69M |
| Shares Change (YoY) | +2.30% |
| Shares Change (QoQ) | +0.22% |
| Owned by Insiders (%) | 1.12% |
| Owned by Institutions (%) | 18.49% |
| Float | 130.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 2,452.41 |
| PB Ratio | 1.41 |
| P/TBV Ratio | 1.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.88, with a Debt / Equity ratio of 0.04.
| Current Ratio | 5.88 |
| Quick Ratio | 5.64 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -375.77 |
Financial Efficiency
Return on equity (ROE) is -67.85% and return on invested capital (ROIC) is -48.94%.
| Return on Equity (ROE) | -67.85% |
| Return on Assets (ROA) | -42.46% |
| Return on Invested Capital (ROIC) | -48.94% |
| Return on Capital Employed (ROCE) | -113.88% |
| Weighted Average Cost of Capital (WACC) | 5.90% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$720,487 |
| Employee Count | 39 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.65% in the last 52 weeks. The beta is 0.30, so MREO's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | -85.65% |
| 50-Day Moving Average | 0.31 |
| 200-Day Moving Average | 0.61 |
| Relative Strength Index (RSI) | 33.05 |
| Average Volume (20 Days) | 9,625,806 |
Short Selling Information
The latest short interest is 4.32 million, so 3.32% of the outstanding shares have been sold short.
| Short Interest | 4.32M |
| Short Previous Month | 3.41M |
| Short % of Shares Out | 3.32% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.53 |
Income Statement
| Revenue | n/a |
| Gross Profit | -1,000 |
| Operating Income | -33.07M |
| Pretax Income | -28.10M |
| Net Income | -28.10M |
| EBITDA | -32.42M |
| EBIT | -33.07M |
| Earnings Per Share (EPS) | -$0.18 |
Balance Sheet
The company has $30.12 million in cash and $1.03 million in debt, with a net cash position of $29.09 million or $0.18 per share.
| Cash & Cash Equivalents | 30.12M |
| Total Debt | 1.03M |
| Net Cash | 29.09M |
| Net Cash Per Share | $0.18 |
| Equity (Book Value) | 28.65M |
| Book Value Per Share | 0.18 |
| Working Capital | 27.72M |
Cash Flow
| Operating Cash Flow | -25.35M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 652,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -25.35M |
| FCF Per Share | -$0.16 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MREO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.30% |
| Shareholder Yield | -2.30% |
| Earnings Yield | -69.69% |
| FCF Yield | -62.86% |
Analyst Forecast
The average price target for MREO is $2.01, which is 696.04% higher than the current price. The consensus rating is "Buy".
| Price Target | $2.01 |
| Price Target Difference | 696.04% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 168.30% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MREO has an Altman Z-Score of -5.08 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.08 |
| Piotroski F-Score | 1 |